InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Daniel William F, 董事. Officer active across 1 company, notably Horizon Therapeutics Public Ltd Co. Cumulatively, 4 reports have been published. History available since 10 May 2021. The latest transaction was disclosed on 6 October 2023 (Disposition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
William F. Daniel is a Board Member at Horizon Therapeutics Public Ltd Co, a biopharmaceutical company. As a board member, he contributes to the strategy and management of the company. His expertise in the pharmaceutical sector is an asset for Horizon.